Related Experiment Video
Updated: Aug 14, 2026

A 3D Quantification Technique for Liver Fat Fraction Distribution Analysis Using Dixon Magnetic Resonance Imaging
Published on: October 20, 2023
Fat-suppressed three-dimensional dual echo Dixon technique for contrast agent enhanced MRI
Jingfei Ma1, Anthony T Vu, Jong Bum Son
1Department of Imaging Physics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. jma@di.mdacc.tmc.edu
This study introduces a faster magnetic resonance imaging method that effectively removes fat signals to provide clearer images of cancer patients after contrast dye injection. By capturing two signals simultaneously, the technique improves image quality and signal strength compared to standard clinical approaches.
Area of Science:
- Medical imaging physics within diagnostic radiology
- Fat-suppressed three-dimensional dual echo Dixon technique applications in oncology
Background:
Current magnetic resonance imaging protocols often struggle to balance scan speed with high-quality fat suppression. That uncertainty drove the need for more efficient acquisition strategies in clinical oncology settings. Prior research has shown that standard gradient echo sequences frequently fail to provide uniform fat removal across complex anatomical regions. This gap motivated the development of advanced signal processing methods to improve diagnostic clarity. Conventional techniques often require longer scan times or suffer from reduced signal strength when suppressing fat. No prior work had resolved the trade-off between rapid imaging and robust fat signal cancellation for contrast-enhanced studies. Investigators have long sought methods to optimize the signal-to-noise ratio while maintaining high spatial resolution. This study addresses these limitations by implementing a dual-echo approach tailored for clinical use.
Purpose Of The Study:
The aim of this study is to develop a rapid T1-weighted imaging method using a dual-echo approach. Researchers sought to overcome the limitations of existing fat suppression techniques in clinical settings. The motivation stemmed from the need for faster, more reliable image acquisition during contrast-enhanced examinations. Standard sequences often fail to provide the necessary image clarity for accurate cancer diagnosis. By implementing a dual-echo strategy, the team intended to improve the overall quality of fat-suppressed scans. They specifically targeted the challenges associated with imaging abdominal and breast tissues in patients. The study also aimed to demonstrate the practical application of this technique in a clinical environment. This work addresses the critical requirement for efficient, high-resolution imaging that remains robust after contrast agent injection.
Main Methods:
The review approach involved modifying a standard product gradient echo pulse sequence to capture two distinct signals. Each radiofrequency excitation event triggered the acquisition of both in-phase and opposed-phase data. An automated on-line reconstruction framework was integrated to separate water and fat components immediately following data collection. Researchers conducted phantom experiments to quantify the signal-to-noise ratio improvements against conventional product sequences. Clinical validation occurred at 1.5 Tesla field strengths using human subjects with known malignancies. The team acquired abdominal and breast images both before and after the administration of gadolinium-based contrast agents. They performed a direct visual and quantitative comparison between the new method and standard fat-suppressed product sequences. This systematic evaluation ensured that the proposed technique met the requirements for high-quality diagnostic imaging in a clinical environment.
Main Results:
Key findings from the literature indicate that the new technique achieves a 41% increase in signal-to-noise ratio within phantom models. This value aligns closely with the theoretical performance predicted by the researchers. In vivo images demonstrate noticeably improved fat suppression compared to standard clinical sequences. The quality of the resulting anatomical images remains high even after the administration of intravenous contrast agents. Patients undergoing abdominal and breast scans showed clearer tissue differentiation with the new method. The dual-echo approach successfully mitigates the artifacts often seen in conventional fat-suppressed imaging. These results confirm that the sequence provides consistent performance across different body regions. The data support the utility of this method for rapid, high-contrast diagnostic applications in oncology.
Conclusions:
The authors demonstrate that their modified sequence achieves superior fat suppression compared to standard clinical protocols. This approach provides high-quality images suitable for contrast-enhanced diagnostic tasks. The researchers report a significant signal-to-noise ratio gain in phantom models consistent with theoretical predictions. Clinical evaluations confirm that the method produces clearer anatomical visualization in both breast and abdominal regions. These findings suggest that the technique is a viable alternative for routine cancer imaging. The study highlights the potential for improved diagnostic confidence when using this faster acquisition strategy. Authors conclude that the dual-echo method effectively handles the challenges of fat signal interference during gadolinium-enhanced scans. Future clinical workflows may benefit from the increased efficiency and image quality offered by this specific pulse sequence modification.
Frequently Asked Questions
The researchers propose that capturing dual echoes allows for the mathematical separation of water and fat signals. This mechanism increases the signal-to-noise ratio by approximately 41% in phantom tests compared to standard sequences without fat suppression.
The team implemented an on-line reconstruction algorithm. This software tool automatically processes raw data to generate distinct images for water and fat, which is necessary for the final diagnostic output.
A 1.5 Tesla magnetic field strength is necessary to maintain consistent imaging parameters across both phantom and human subjects. This field intensity allows for the direct comparison between the new technique and the standard product sequence.
Gadolinium contrast agent serves as the primary data type for enhancing tissue visibility. This substance is injected intravenously to highlight cancerous lesions, allowing the researchers to evaluate the effectiveness of the fat suppression during contrast-enhanced scans.
The researchers measured the signal-to-noise ratio in phantom models. This measurement provides a quantitative baseline to compare the performance of the new technique against the existing product sequence without fat suppression.
The authors claim that this method provides excellent image quality for T1-weighted imaging. They suggest it is a robust solution for clinical scenarios requiring both fat suppression and contrast enhancement.
More Related Videos
Related Concept Videos
Magnetic Resonance Imaging
Imaging Studies for Cardiovascular System IV: CMRI

